FSBEI HE 'Peoples' Friendship University of Russia', Moscow, Russia.
City clinical hospital named V. V. Vinogradov, Moscow, Russia.
Gynecol Endocrinol. 2020;36(sup1):12-15. doi: 10.1080/09513590.2020.1816721.
Endometriosis is one of the most common gynecological diseases diagnosed in almost 70% of patients with chronic pelvic pain (CPP). However, a quarter of women with pelvic pain is diagnosed with external genital endometriosis (EGE) during laparoscopy. A special group is represented by patients with PP that did not stop after the removal of endometrial foci. The mechanisms of the pathogenesis of the formation of pain syndrome are not completely explored yet. According to several authors, a significant role in the pathogenesis of pelvic pain recurrence after surgical treatment of EGE is played by active neuroangiogenesis, both in ectopic and eutopic endometrium. The aim of the study was to expand the understanding of the pathogenesis of pelvic pain that did not stop (recurrence) after surgical treatment of external genital endometriosis.
The study involved 2 stages. At the first stage (algological), data from B&B, NRS and VRS algological questionnaires, which were completed by patients with recurrent PP after surgical treatment of EGE, were analyzed ( = 130, aged 18-45 years old, average age 32.5 ± 7.6 years). All women were operated on for EGE no later than 3-6 months after assessing the patients by the algological questionnaires; they did not receive drug therapy after surgical treatment and sought medical attention for recurrent pelvic pain. Materials for the study of the endometrium were obtained by the pipelle biopsymethod. The control group was formed from a number of women with EGE without PP, who applied for surgical treatment of infertility ( = 30).
The results of the study have shown that the basis of pathogenesis of pelvic pain recurrence in patients who did not receive medical therapy after surgical treatment of EGE is the activation of neuro-angiogenesis processes and reduction of apoptosis. The results show a statistically significant 1.6 times increasing expression of NGF in eutopic endometrium (57.9 ± 2.5 vs 35.3 ± 2.1% of patients with the silent form of the gene and its receptor NTRK1 1.8 times (2.78 ± 0.25 versus 1.56 ± 0.21.e. respectively). The pathogenesis of pelvic pain in patients who did not receive medical therapy after surgical treatment of endometriosis compared to no pain form of the disease is the activation of the processes of neurogenesis in the eutopic endometrium.
子宫内膜异位症是妇科最常见的疾病之一,约 70%的慢性盆腔痛(CPP)患者被诊断为此病。然而,在腹腔镜检查中,四分之一的盆腔痛患者被诊断为外阴子宫内膜异位症(EGE)。一个特殊的群体是指那些在切除子宫内膜病灶后,盆腔痛仍未停止的患者。发病机制中的疼痛综合征的发病机制尚未完全探索。根据几位作者的观点,在外阴子宫内膜异位症的手术治疗后,盆腔疼痛复发的发病机制中,神经血管生成的活跃起着重要作用,无论是在异位内膜还是在位内膜中。本研究的目的是扩大对外阴子宫内膜异位症手术治疗后盆腔疼痛(复发)的发病机制的理解。
该研究分两个阶段进行。在第一阶段(痛觉学),对接受过 EGE 手术治疗后复发的 CPP 患者进行 B&B、NRS 和 VRS 痛觉学问卷的数据分析( = 130,年龄 18-45 岁,平均年龄 32.5 ± 7.6 岁)。所有接受手术治疗的女性均在接受痛觉学问卷评估后 3-6 个月内接受 EGE 手术治疗;她们在手术治疗后没有接受药物治疗,并因复发的盆腔疼痛而寻求医疗帮助。子宫内膜的研究材料是通过 pipelle 活检方法获得的。对照组由一组没有盆腔疼痛的 EGE 患者组成,他们因不孕而接受手术治疗( = 30)。
研究结果表明,在接受 EGE 手术后未接受药物治疗的患者中,盆腔疼痛复发的发病机制基础是神经血管生成过程的激活和细胞凋亡的减少。研究结果显示,NGF 在在位子宫内膜中的表达增加了 1.6 倍(57.9 ± 2.5 比沉默形式的基因及其受体 NTRK1 的 35.3 ± 2.1%,NGF 及其受体 NTRK1 的表达分别增加了 1.8 倍(2.78 ± 0.25 比 1.56 ± 0.21.e)。与疾病无疼痛形式相比,接受子宫内膜异位症手术后未接受药物治疗的患者的盆腔疼痛发病机制是在位子宫内膜中神经发生过程的激活。